Anti Cancer Injection

Product Details:

Nindanib 150 mg Cap is an oral capsule that contains Nintedanib, a tyrosine kinase inhibitor (TKI). It is primarily used to treat idiopathic pulmonary fibrosis (IPF) and other fibrotic lung diseases by inhibiting multiple signaling pathways involved in the progression of fibrosis and inflammation. Nintedanib works by targeting and blocking key proteins that are involved in the abnormal growth of tissue, helping to reduce lung scarring and slow the decline in lung function.

The medication helps to stabilize lung function, reduce the worsening of symptoms, and improve the quality of life for individuals with IPF and other interstitial lung diseases. It is generally used in combination with other treatments or therapies as part of a comprehensive care plan.

Brand Name: Nindanib
Generic Name: Nintedanib
Strength: 150 mg
Form: Oral Capsule
Therapeutic Class: Tyrosine Kinase Inhibitor (TKI)
Prescription Required: Yes

• Idiopathic Pulmonary Fibrosis (IPF): A lung disease that causes scarring and thickening of lung tissue, making it difficult to breathe.

• Other Interstitial Lung Diseases (ILDs): A group of diseases that cause inflammation and scarring in the lung tissue.

• Fibrotic Lung Conditions: To slow the progression of fibrosis (the thickening and scarring of connective tissue) in the lungs.

• Take one capsule of Nindanib 150 mg twice daily, with food.

• Swallow the capsule whole with a glass of water. Do not chew, crush, or open the capsule.

• The typical dosage is 150 mg twice a day (total of 300 mg per day), but your doctor may adjust your dose based on your response to treatment and tolerance.

• If you miss a dose, take it as soon as you remember, unless it is almost time for your next dose. Do not take two doses at once to make up for a missed dose.

• Do not stop taking Nindanib without consulting your doctor, as sudden discontinuation may affect your treatment progress.

Nindanib 150 mg Cap is used for the treatment of:

• Idiopathic Pulmonary Fibrosis (IPF), a progressive lung disease characterized by scarring of lung tissue.

• Other interstitial lung diseases (ILDs), which involve inflammation and fibrosis in the lungs.

• To slow the progression of fibrosis and improve lung function in individuals with these conditions.

Nindanib works as a tyrosine kinase inhibitor (TKI), targeting specific enzymes and signaling pathways involved in the abnormal growth of tissue. By blocking these enzymes, Nintedanib helps to reduce inflammation and fibrosis in the lungs, slowing the progression of lung scarring, and preserving lung function.

• Take one capsule of Nindanib 150 mg twice a day with food, as directed by your healthcare provider.

• Swallow the capsule whole; do not chew, crush, or open it.

• You can take the medication with or without water, but it is best taken with food to reduce potential stomach irritation.